Lætitia Ligat

1.3k total citations
21 papers, 636 citations indexed

About

Lætitia Ligat is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Lætitia Ligat has authored 21 papers receiving a total of 636 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Lætitia Ligat's work include Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (5 papers). Lætitia Ligat is often cited by papers focused on Glycosylation and Glycoproteins Research (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Immune Cell Function and Interaction (5 papers). Lætitia Ligat collaborates with scholars based in France, Réunion and United Kingdom. Lætitia Ligat's co-authors include Gilles Favre, Aurélien Olichon, Nicolas Béry, Laura Keller, Virginie Bernard, Sandrine Moutel, Ario de Marco, Jean‐Christophe Rain, Franck Perez and Jean‐Jacques Fournié and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Molecular and Cellular Biology.

In The Last Decade

Lætitia Ligat

21 papers receiving 632 citations

Peers

Lætitia Ligat

RNMI

IMMUN

ONCOL

Stephanie C. Pero United States

С. С. Богачев Russia

Johannes W. Pedersen Denmark

Niranjan B. Pandey United States

James P. Vaughn United States

Fritz Rudert Germany

Hanne Merritt United States

Philip M. Santiago United States

Csilla A. Fenczik United States

Martha L. Peterson United States

Stephanie C. Pero United States

Lætitia Ligat

633 ×1.6

373 ×1.8

RNMI

131 ×0.9

IMMUN

284 ×2.3

ONCOL

38 ×0.4

Citations per year, relative to Lætitia Ligat Lætitia Ligat (= 1×) peers Stephanie C. Pero

Countries citing papers authored by Lætitia Ligat

Since Specialization

Citations

This map shows the geographic impact of Lætitia Ligat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lætitia Ligat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lætitia Ligat more than expected).

Fields of papers citing papers by Lætitia Ligat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lætitia Ligat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lætitia Ligat. The network helps show where Lætitia Ligat may publish in the future.

Co-authorship network of co-authors of Lætitia Ligat

This figure shows the co-authorship network connecting the top 25 collaborators of Lætitia Ligat. A scholar is included among the top collaborators of Lætitia Ligat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lætitia Ligat. Lætitia Ligat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rolland, Corinne, Anissa Edir, Astrid Canivet, et al.. (2025). Bispecific nanobody® as a new pharmacological drug for the selective inhibition of Trypsin‐3. British Journal of Pharmacology. 182(19). 4578–4591. 1 indexed citations

Ligat, Lætitia, et al.. (2023). Defeating gemcitabine resistance in pancreatic tumours with antibody-based CDA degrader. Pancreatology. 23. e12–e12. 1 indexed citations

Keller, Laura, Claudine Tardy, Lætitia Ligat, et al.. (2022). Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling. Frontiers in Immunology. 13. 980539–980539. 1 indexed citations

Ligat, Lætitia, Frédéric Lopez, Jean‐Jacques Fournié, et al.. (2021). Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins. Cellular and Molecular Immunology. 18(8). 1861–1870. 24 indexed citations

Ysebaert, Loïc, Lætitia Ligat, Frédéric Lopez, et al.. (2021). IL-10 Rescues CLL Survival through Repolarization of Inflammatory Nurse-like Cells. Cancers. 14(1). 16–16. 11 indexed citations

Bellande, Kevin, et al.. (2020). Recombinant N-glycosylation isoforms of Legume lectins: Production and purification from Nicotiana benthamiana leaves following RuBisCO depletion. Plant Physiology and Biochemistry. 157. 441–452. 2 indexed citations

Hanoun, Naı̈ma, Lætitia Ligat, Hubert Lulka, et al.. (2020). The E3 ubiquitin ligase TRIP12 participates in cell cycle progression and chromosome stability. Scientific Reports. 10(1). 789–789. 23 indexed citations

Franchini, Don‐Marc, Olivia Lanvin, Marie Tosolini, et al.. (2019). Microtubule-Driven Stress Granule Dynamics Regulate Inhibitory Immune Checkpoint Expression in T Cells. Cell Reports. 26(1). 94–107.e7. 39 indexed citations

Keller, Laura, Nicolas Béry, Claudine Tardy, et al.. (2019). Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities. Antibodies. 8(1). 8–8. 23 indexed citations

10.

Hantelys, Fransky, Anne-Claire Godet, Florian David, et al.. (2019). Vasohibin1, a new mouse cardiomyocyte IRES trans-acting factor that regulates translation in early hypoxia. eLife. 8. 17 indexed citations

11.

Weiswald, Louis‐Bastien, Marcella De Giorgi, Émilie Brotin, et al.. (2018). Abstract 3996: Pyridoclax and its derivatives from oligopyridine family directly inhibit Mcl-1 and exert potent antitumor effects on ovarian cancer in vitro and in vivo. Cancer Research. 78(13_Supplement). 3996–3996. 1 indexed citations

12.

Rossi, Cédric, Pauline Gravelle, Mary Poupot, et al.. (2018). Boosting γδ T cell-mediated antibody-dependent cellular cytotoxicity by PD-1 blockade in follicular lymphoma. OncoImmunology. 8(3). 1554175–1554175. 50 indexed citations

13.

Moutel, Sandrine, Nicolas Béry, Virginie Bernard, et al.. (2016). NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies. eLife. 5. 226 indexed citations

14.

Tosolini, Marie, Lætitia Ligat, Anne Quillet‐Mary, et al.. (2016). Nurse-like cells promote CLL survival through LFA-3/CD2 interactions. Oncotarget. 8(32). 52225–52236. 26 indexed citations

15.

Ligat, Lætitia, Nathalie Saint‐Laurent, Véronique Gigoux, et al.. (2015). Pancreatic preneoplastic lesions plasma signatures and biomarkers based on proteome profiling of mouse models. British Journal of Cancer. 113(11). 1590–1598. 15 indexed citations

16.

Zischek, Claudine, Lætitia Ligat, Alice Boulanger, et al.. (2015). The N-Glycan Cluster from Xanthomonas campestris pv. campestris. Journal of Biological Chemistry. 290(10). 6022–6036. 29 indexed citations

17.

Tosolini, Marie, Frédéric Pont, Emmanuel Ravet, et al.. (2014). Human Monocyte Recognition of Adenosine-Based Cyclic Dinucleotides Unveils the A2a G_αsProtein-Coupled Receptor Tonic Inhibition of Mitochondrially Induced Cell Death. Molecular and Cellular Biology. 35(2). 479–495. 18 indexed citations

18.

Chinestra, Patrick, Aurélien Olichon, Isabelle Lajoie‐Mazenc, et al.. (2014). Generation of a Single Chain Antibody Variable Fragment (scFv) to Sense Selectively RhoB Activation. PLoS ONE. 9(11). e111034–e111034. 4 indexed citations

19.

Ligat, Lætitia, Emmanuelle Lauber, Cécile Albenne, et al.. (2011). Analysis of the xylem sap proteome of Brassica oleracea reveals a high content in secreted proteins. PROTEOMICS. 11(9). 1798–1813. 79 indexed citations

20.

Corellou, Florence, Alain Camasses, Lætitia Ligat, Gérard Peaucellier, & François‐Yves Bouget. (2005). Atypical Regulation of a Green Lineage-Specific B-Type Cyclin-Dependent Kinase. PLANT PHYSIOLOGY. 138(3). 1627–1636. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact